Comments on: Trends in 2009: Personalized Medicine and Cancer Update http://crossborderbiotech.ca/2009/03/05/trends-in-2009-personalized-medicine-and-cancer-update/ Biotechnology, Health and Business in Canada, the United States and Worldwide Mon, 02 Apr 2012 12:31:04 +0000 hourly 1 http://wordpress.com/ By: Trends Update — “Personalized Effectiveness”: Amgen Gets Prospective Data to Back KRAS-Vectibix Plan « The Cross-Border Biotech Blog http://crossborderbiotech.ca/2009/03/05/trends-in-2009-personalized-medicine-and-cancer-update/comment-page-1/#comment-791 Tue, 11 Aug 2009 18:23:30 +0000 http://crossborderbiotech.ca/?p=859#comment-791 [...] tumor genotyping as a standard of care; [...]

]]> By: Trends Update — Personalized Medicine: DxS’ Latest Companion Diagnostics Deal « The Cross-Border Biotech Blog http://crossborderbiotech.ca/2009/03/05/trends-in-2009-personalized-medicine-and-cancer-update/comment-page-1/#comment-459 Sun, 31 May 2009 17:32:17 +0000 http://crossborderbiotech.ca/?p=859#comment-459 [...] 31, 2009 · No Comments As personalized medicine inches toward becoming the standard of care for cancer, the question of who pays for the genotyping becomes more important.  A deal announced Friday [...]

]]>